News

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week

Investigators have found that children who received a flu shot in consecutive years did not see a decline in vaccine effectiveness.

ViiV Healthcare has announced that a long-acting injectable 2-drug regimen has met its primary endpoint in the FLAIR study of virally suppressed adults with HIV.

Investigators have found the quadrivalent vaccination to be as effective as trivalent standard-dose, while the high-dose trivalent was found to be more effective than the trivalent standard-dose.

A long-acting injectable regimen of cabotegravir and rilpivirine has demonstrated high rates of virologic response, long-term durability, and good overall tolerability at 160 weeks.

Keeping communities safe from potentially deadly viruses is everyone’s responsibility.

Drug-resistant mutations in certain HIV strains do not appear to affect disease progression before antiretroviral therapy is initiated, but other variables may play a role.

The results of a new study demonstrate that PrEP can reduce new infections within a population even when the risk of HIV remains high and other proven treatment and prevention strategies are optimized.

Polio could soon be completely eradicated, but public health officials have an intricate set of steps to ensure a lasting defeat.

Sanofi Pasteur’s dengue vaccine (Dengvaxia) is moving one step closer to being approved in the United States as the FDA just accepted a Biologics License Application for the vaccine.

Results for SYMTUZA continue to be positive as the latest data indicate that 85% of study participants achieved virologic suppression (viral load

New research confirms a link between initiation of antiretroviral therapy and an increase in herpes viral shedding; however, the results suggest the spike in shedding is only temporary.

Men who have sex with men who seek out sexual partners online are more likely to report sexually transmitted infections, including syphilis, gonorrhea, and chlamydia.

The results of a new study suggest that a high-dose trivalent influenza vaccine recommended for older adults may also benefit patients with kidney disease who are on dialysis.

Chlorhexidine gluconate bathing plays a large role in infection prevention practices and patient buy-in is an important aspect of ensuring compliance.

The proliferation of malaria-specific cord blood CD4+ T cells is associated with protection from childhood malaria.

Despite concerning findings and warnings, fluoroquinolones have remained one of the world’s most commonly prescribed antibiotic classes, with the United States accounting for more than 32 million prescriptions in 2015 alone.

Men who experienced seroconversion following the advent of antiviral therapy (circa 1996) and who received treatment were found to be more likely to reduce risk behaviors.

We’ve rounded up a list of recalls issued by the US Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Building on decades-old research, scientists in France say they’ve developed an effective rectal delivery formulation of an antibiotic used to save infants with life-threatening neonatal sepsis.

A new study suggests that combined antiretroviral treatment in patients with HIV does not prevent viral load rebound in semen after the treatment is paused.

A new study by investigators in Japan finds that earlier antibiotic stewardship intervention decreased antibiotic usage and costs and were associated with reduced rates of antibiotic resistance.

People with HIV display signs of advanced aging when certain biomarkers are studied.

In a plenary at the HIV Research for Prevention conference, Anthony Fauci, MD, discussed the need for implementation of new HIV prevention mechanisms.

Because of the recent concern in the United States around the rise of resistant pathogens, intravenous fosfomycin has gained renewed interest because of its activity and demonstrated synergy with other classes of antibiotics.

The assays are supported by the ID NOW platform with an instrument-based isothermal system for the qualitative detection of infectious diseases.

A new study highlights the potential predictive power of genome sequencing.